ClinicalTrials.gov record
Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V)
ClinicalTrials.gov ID: NCT03801525
Public ClinicalTrials.gov record NCT03801525. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2/3 Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects With Chronic Lymphocytic Leukemia (CLL)
Study identification
- NCT ID
- NCT03801525
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- TG Therapeutics, Inc.
- Industry
- Enrollment
- 277 participants
Conditions and interventions
Interventions
- Ublituximab Drug
- Umbralisib Drug
- Venetoclax Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 15, 2019
- Primary completion
- Dec 19, 2022
- Completion
- Dec 19, 2022
- Last update posted
- Apr 18, 2024
2019 – 2022
United States locations
- U.S. sites
- 50
- U.S. states
- 29
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TG Therapeutics Investigational Trial Site | Birmingham | Alabama | 35294 | — |
| TG Therapeutics Investigational Trial Site | Huntsville | Alabama | 35805 | — |
| TG Therapeutics Investigational Trial Site | Tucson | Arizona | 85711 | — |
| TG Therapeutics Investigational Trial Site | Duarte | California | 91010 | — |
| TG Therapeutics Investigational Trial Site | La Jolla | California | 92093 | — |
| TG Therapeutics Investigational Trial Site | Aurora | Colorado | 80012 | — |
| TG Therapeutics Investigational Trial Site | Stamford | Connecticut | 06904 | — |
| TG Therapeutics Investigational Trial Site | Boca Raton | Florida | 33486 | — |
| TG Therapeutics Investigational Trial Site | Fort Myers | Florida | 33901 | — |
| TG Therapeutics Investigational Trial Site | Jacksonville | Florida | 32224 | — |
| TG Therapeutics Investigational Trial Site | St. Petersburg | Florida | 33705 | — |
| TG Therapeutics Investigational Trial Site | Tampa | Florida | 33612 | — |
| TG Therapeutics Investigational Trial Site | Atlanta | Georgia | 30322 | — |
| TG Therapeutics Investigational Trial Site | Decatur | Illinois | 62526 | — |
| TG Therapeutics Investigational Trial Site | Niles | Illinois | 60714 | — |
| TG Therapeutics Investigational Site | Peoria | Illinois | 61615 | — |
| TG Therapeutics Investigational Trial Site | Fort Wayne | Indiana | 46804 | — |
| TG Therapeutics Investigational Trial Site | Indianapolis | Indiana | 46237 | — |
| TG Therapeutics Investigational Trial Site | Des Moines | Iowa | 50309 | — |
| TG Therapeutics Investigational Trial Site | Westwood | Kansas | 66210 | — |
| TG Therapeutics Investigational Site | Louisville | Kentucky | 40207 | — |
| TG Therapeutics Investigational Trial Site | Bethesda | Maryland | 37210 | — |
| TG Therapeutics Investigational Trial Site | Columbia | Maryland | 21044 | — |
| TG Therapeutics Investigational Trial Site | Ann Arbor | Michigan | 48197 | — |
| TG Therapeutics Investigational Trial Site | Detroit | Michigan | 48201 | — |
| TG Therapeutics Investigational Trial Site | Detroit | Michigan | 48202 | — |
| TG Therapeutics Investigational Trial Site | Rochester | Minnesota | 55905 | — |
| TG Therapeutics Investigational Trial Site | Omaha | Nebraska | 68198 | — |
| TG Therapeutics Investigational Trial Site | Lebanon | New Hampshire | 03756 | — |
| TG Therapeutics Investigational Trial Site | Hackensack | New Jersey | 07601 | — |
| TG Therapeutics Investigational Trial Site | Morristown | New Jersey | 07960 | — |
| TG Therapeutics Investigational Trial Site | New York | New York | 10065 | — |
| TG Therapeutics Investigational Trial Site | Charlotte | North Carolina | 28204 | — |
| TG Therapeutics Investigational Trial Site | Columbus | Ohio | 43210 | — |
| TG Therapeutics Investigational Trial Site | Eugene | Oregon | 97401 | — |
| TG Therapeutics Investigational Trial Site | Philadelphia | Pennsylvania | 19106 | — |
| TG Therapeutics Investigational Trial Site | Charleston | South Carolina | 29414 | — |
| TG Therapeutics Investigational Trial Site | Greenville | South Carolina | 29616 | — |
| TG Therapeutics Investigational Trial Site | Chattanooga | Tennessee | 37404 | — |
| TG Therapeutics Investigational Trial Site | Knoxville | Tennessee | 37916 | — |
| TG Therapeutics Investigational Trial Site | Nashville | Tennessee | 37203 | — |
| TG Therapeutics Investigational Trial Site | Austin | Texas | 78705 | — |
| TG Therapeutics Investigational Trial Site | San Antonio | Texas | 78229 | — |
| TG Therapeutics Investigational Trial Site | Tyler | Texas | 75702 | — |
| TG Therapeutics Investigational Trial Site | Ogden | Utah | 84405 | — |
| TG Therapeutics Investigational Trial Site | Salt Lake City | Utah | 84106 | — |
| TG Therapeutics Investigational Trial Site | Blacksburg | Virginia | 24060 | — |
| TG Therapeutics Investigational Trial Site | Gainesville | Virginia | 20155 | — |
| TG Therapeutics Investigational Trial Site | Seattle | Washington | 98104 | — |
| TG Therapeutics Investigational Trial Site | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03801525, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2024 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03801525 live on ClinicalTrials.gov.